John R. Sedor

14.9k total citations · 1 hit paper
150 papers, 6.2k citations indexed

About

John R. Sedor is a scholar working on Nephrology, Molecular Biology and Genetics. According to data from OpenAlex, John R. Sedor has authored 150 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Nephrology, 48 papers in Molecular Biology and 28 papers in Genetics. Recurrent topics in John R. Sedor's work include Renal Diseases and Glomerulopathies (69 papers), Chronic Kidney Disease and Diabetes (42 papers) and Renal and related cancers (16 papers). John R. Sedor is often cited by papers focused on Renal Diseases and Glomerulopathies (69 papers), Chronic Kidney Disease and Diabetes (42 papers) and Renal and related cancers (16 papers). John R. Sedor collaborates with scholars based in United States, Russia and Japan. John R. Sedor's co-authors include Martha Konieczkowski, Jeffrey R. Schelling, Robert L. Thomas, Yuichi NAKAZATO, M. S. Simonson, Leslie A. Bruggeman, Michael J. Dünn, Paolo Mené, Mark Kester and John F. O’Toole and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

John R. Sedor

146 papers receiving 6.1k citations

Hit Papers

Endothelin stimulates phospholipase C, Na+/H+ exchange, c... 1989 2026 2001 2013 1989 100 200 300 400

Peers

John R. Sedor
John Cijiang He United States
Gang Xu China
Leon G. Fine United States
David A. Power Australia
John R. Sedor
Citations per year, relative to John R. Sedor John R. Sedor (= 1×) peers Tomoko Takano

Countries citing papers authored by John R. Sedor

Since Specialization
Citations

This map shows the geographic impact of John R. Sedor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Sedor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Sedor more than expected).

Fields of papers citing papers by John R. Sedor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Sedor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Sedor. The network helps show where John R. Sedor may publish in the future.

Co-authorship network of co-authors of John R. Sedor

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Sedor. A scholar is included among the top collaborators of John R. Sedor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Sedor. John R. Sedor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Modi, Zubin J., Wenjun Ju, Edmond Lee, et al.. (2024). Precision Medicine Proof-of-Concept Study of a TNF Inhibitor in FSGS and Treatment-Resistant Minimal Change Disease. Kidney360. 6(2). 284–295. 1 indexed citations
2.
Veličković, Dušan, John P. Shapiro, Samir V. Parikh, et al.. (2024). Protein N-Glycans in Healthy and Sclerotic Glomeruli in Diabetic Kidney Disease. Journal of the American Society of Nephrology. 35(9). 1198–1207. 7 indexed citations
3.
Nakhoul, Georges, Jonathan J. Taliercio, Susana Arrigain, et al.. (2024). Virtual Nephron: Evaluation of a Novel Virtual Reality Educational Tool. Kidney International Reports. 9(9). 2619–2626. 1 indexed citations
4.
Madhavan, Sethu M., Martha Konieczkowski, Leslie A. Bruggeman, et al.. (2022). Essential role of Wtip in mouse development and maintenance of the glomerular filtration barrier. American Journal of Physiology-Renal Physiology. 323(3). F272–F287. 3 indexed citations
5.
Wu, Zhenzhen, Sethu M. Madhavan, Michelle Chen, et al.. (2021). Lack of APOL1 in proximal tubules of normal human kidneys and proteinuric APOL1 transgenic mouse kidneys. PLoS ONE. 16(6). e0253197–e0253197. 4 indexed citations
6.
Freedman, Barry I., Wylie Burke, Jasmin Divers, et al.. (2021). Diagnosis, Education, and Care of Patients with APOL1-Associated Nephropathy: A Delphi Consensus and Systematic Review. Journal of the American Society of Nephrology. 32(7). 1765–1778. 9 indexed citations
7.
Azhibekov, Timur, John F. O’Toole, John R. Sedor, et al.. (2020). Association of preeclampsia with infant APOL1 genotype in African Americans. BMC Medical Genetics. 21(1). 110–110. 19 indexed citations
8.
Bruggeman, Leslie A., Zhenzhen Wu, Liping Luo, et al.. (2019). APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy. PLoS ONE. 14(10). e0224408–e0224408. 21 indexed citations
9.
Schold, Jesse D., Joshua J. Augustine, Anne M. Huml, et al.. (2019). Modest rates and wide variation in timely access to repeat kidney transplantation in the United States. American Journal of Transplantation. 20(3). 769–778. 24 indexed citations
10.
Bruggeman, Leslie A., John F. O’Toole, & John R. Sedor. (2018). APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?. American Journal of Physiology-Renal Physiology. 316(1). F1–F8. 18 indexed citations
11.
Shah, Anuja, Cynthia C. Nast, Mark D. Adams, et al.. (2014). Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing. eScholarship (California Digital Library). 1 indexed citations
12.
Miao, Hui, Da‐Qiang Li, Amitava Mukherjee, et al.. (2009). EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt. Cancer Cell. 16(1). 9–20. 412 indexed citations
13.
Satko, Scott G., John R. Sedor, Sudha K. Iyengar, & Barry I. Freedman. (2007). Familial Clustering of Chronic Kidney Disease. Seminars in Dialysis. 20(3). 229–236. 76 indexed citations
14.
Khan, Saeed R., Karen Wu, John R. Sedor, Bassam G. Abu Jawdeh, & Jeffrey R. Schelling. (2006). The NHE1 Na+/H+ exchanger regulates cell survival by activating and targeting ezrin to specific plasma membrane domains.. PubMed. 52(8). 115–21. 13 indexed citations
15.
Jarad, George, Jeffrey S. Simske, John R. Sedor, & Jeffrey R. Schelling. (2003). Nucleic acid-based techniques for post-transcriptional regulation of molecular targets. Current Opinion in Nephrology & Hypertension. 12(4). 415–421. 7 indexed citations
16.
El‐Meanawy, Ashraf, et al.. (2003). DNA expression analysis: serial analysis of gene expression, microarrays and kidney disease. Current Opinion in Nephrology & Hypertension. 12(4). 407–414. 14 indexed citations
17.
Liu, Jianmin, Lei Zhang, Dongmei Wang, et al.. (2003). Congenital diaphragmatic hernia, kidney agenesis and cardiac defects associated with Slit3-deficiency in mice. Mechanisms of Development. 120(9). 1059–1070. 99 indexed citations
18.
Iyengar, Sudha K., Jeffrey R. Schelling, & John R. Sedor. (2002). Approaches to understanding susceptibility to nephropathy: From genetics to genomics. Kidney International. 61(1). S61–S67. 13 indexed citations
19.
Schelling, Jeffrey R., et al.. (2002). Generation of Kidney Transcriptomes Using Serial Analysis of Gene Expression. Nephron Experimental Nephrology. 10(2). 82–92. 9 indexed citations
20.
Covic, Adrian, et al.. (2000). Analysis of the effect of hemodialysis on peripheral and central arterial pressure waveforms. Kidney International. 57(6). 2634–2643. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026